SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 236.90 |
| Enterprise Value ($M) | 198.99 |
| Book Value ($M) | 362.33 |
| Book Value / Share | 3.18 |
| Price / Book | 0.65 |
| NCAV ($M) | 177.65 |
| NCAV / Share | 1.56 |
| Price / NCAV | 1.33 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.39 |
| Return on Assets (ROA) | -0.33 |
| Return on Equity (ROE) | -0.44 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 8.29 |
| Current Ratio | 8.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 310.29 |
| Assets | 494.97 |
| Liabilities | 132.64 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Point72 Asset Management, L.P. | 0.00 | -100.00 | |
| 13G/A | BlackRock, Inc. | 9.20 | 0.00 | |
| 13G/A | Boxer Capital Management, LLC | 4.40 | ||
| 13D/A | Redmile Group, LLC | 14.90 | 17.07 | |
| 13G/A | Vanguard Group Inc | 9.43 | -6.47 | |
| 13G | Boxer Capital, LLC | 6.30 | ||
| 13G/A | Capital World Investors | 0.00 | -100.00 | |
| 13G/A | State Street Corp | 1.89 | -18.05 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 477,781 | 1,557,503 | 30.68 | |
| 408,217 | 1,618,329 | 25.22 | |
| 439,166 | 1,621,652 | 27.08 | |
| 213,569 | 920,832 | 23.19 | |
| 223,610 | 1,014,653 | 22.04 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ESPR – Esperion Therapeutics, Inc. | ETNB – 89bio, Inc. |
| ETON – Eton Pharmaceuticals, Inc. | FBLG – FibroBiologics, Inc. |
| FHTX – Foghorn Therapeutics Inc. |